The C-terminal cytoplasmic domain of human proEGF is a negative modulator of body and organ weights in transgenic mice

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

We generated transgenic mice to study the in vivo role of the cytoplasmic domain of human proEGF (proEGFcyt). Post-pubertal proEGFcyt transgenic (tg) mice displayed an up to 15% reduction in body weight, including smaller kidney and brain weights as compared to control littermates. Renal histology, gene expression profiles, and functional parameters were normal. In both sexes, serum levels of IGFBP-3 were reduced. Circulating IGF-I/IGF-II levels were unchanged. Histomorphological analysis revealed isolated foci of liver necrosis specific to proEGFcyt tg mice. In conclusion, we identified proEGF cytoplasmic domain as a novel modulator of whole body and organ-specific growth in mice. © 2009 Federation of European Biochemical Societies.

Cite

CITATION STYLE

APA

Klonisch, T., Glogowska, A., Gratao, A. A., Grzech, M., Nistor, A., Torchia, M., … Schneider, M. R. (2009). The C-terminal cytoplasmic domain of human proEGF is a negative modulator of body and organ weights in transgenic mice. FEBS Letters, 583(8), 1349–1357. https://doi.org/10.1016/j.febslet.2009.03.051

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free